Addex Stock Performance

ADXN Stock  USD 1.16  0.10  9.43%   
Addex Therapeutics holds a performance score of 11 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.2682, which signifies a somewhat significant risk relative to the market. Let's try to break down what Addex's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Addex Therapeutics will likely underperform. Although it is vital to follow Addex Therapeutics historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. Our philosophy in foreseeing future performance of any stock is to look not only at its past charts but also at the business as a whole, including all fundamental and technical indicators. To evaluate if Addex Therapeutics expected return of 1.31 will be sustainable into the future, we have found twenty-eight different technical indicators, which can help you to check if the expected returns are sustainable. Use Addex Therapeutics expected short fall, rate of daily change, as well as the relationship between the maximum drawdown and information ratio to analyze future returns on Addex Therapeutics.

Addex Performance

11 of 100

Compared to the overall equity markets, risk-adjusted returns on investments in Addex Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Addex Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow18.7 M
Total Cashflows From Investing Activities-30.3 K

Addex Therapeutics Relative Risk vs. Return Landscape

If you would invest  60.00  in Addex Therapeutics on December 24, 2022 and sell it today you would earn a total of  46.00  from holding Addex Therapeutics or generate 76.67% return on investment over 90 days. Addex Therapeutics is currently generating 1.313% in daily expected returns and assumes 8.5687% risk (volatility on return distribution) over the 90 days horizon. In different words, 74% of stocks are less volatile than Addex, and 75% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Addex Therapeutics is expected to generate 8.95 times more return on investment than the market. However, the company is 8.95 times more volatile than its market benchmark. It trades about 0.15 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly -0.05 per unit of risk.

Addex Therapeutics Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Addex Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Addex Therapeutics, and traders can use it to determine the average amount a Addex Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1532

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsADXN
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

  actual daily
74% of assets are less volatile

Expected Return

  actual daily
75% of assets have higher returns

Risk-Adjusted Return

  actual daily
89% of assets perform better
Based on monthly moving average Addex Therapeutics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Addex Therapeutics by adding it to a well-diversified portfolio.

Addex Therapeutics Fundamentals Growth

Addex Stock prices reflect investors' perceptions of the future prospects and financial health of Addex Therapeutics, and Addex Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Addex Stock performance.

About Addex Therapeutics Performance

To evaluate Addex Therapeutics Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Addex Therapeutics generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Addex Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Addex Therapeutics market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Addex's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2023
Effect of Exchange Rate Changes on Cash110.2 K118.9 K
Return on Average Assets(0.62) (0.67) 
Return on Average Equity(0.82) (0.88) 
Return on Invested Capital 17.24  18.60 
Return on Sales(4.72) (5.09) 

Things to note about Addex Therapeutics performance evaluation

Checking the ongoing alerts about Addex Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Addex Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Addex Therapeutics is way too risky over 90 days horizon
Addex Therapeutics may become a speculative penny stock
Addex Therapeutics appears to be risky and price may revert if volatility continues
Addex Therapeutics is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 2.92 M. Net Loss for the year was (15.35 M) with loss before overhead, payroll, taxes, and interest of (9.69 M).
Addex Therapeutics currently holds about 8.81 M in cash with (14.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.4, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Addex Therapeutics has a frail financial position based on the latest SEC disclosures
Latest headline from Should You Accumulate Addex Therapeutics Ltd - ADR Stock Tuesday Morning - InvestorsObserver
Evaluating Addex Therapeutics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Addex Therapeutics' stock performance include:
  • Analyzing Addex Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Addex Therapeutics' stock is overvalued or undervalued compared to its peers.
  • Examining Addex Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Addex Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Addex Therapeutics' management team can help you assess the company's leadership.
  • Pay attention to analyst opinions and ratings of Addex Therapeutics' stock. These opinions can provide insight into Addex Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Addex Therapeutics' stock performance is not an exact science, and many factors can impact Addex Therapeutics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities. To learn how to invest in Addex Stock please use our How to Invest in Addex Therapeutics guide. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for analysis

When running Addex Therapeutics price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Addex Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.